This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment and prognosis

Authoring team

The treatment options for a patient with the cholesterol emboli syndrome are limited:

  • multiple treatment regimens have been generally unsuccessful in altering the course of the disease process
    • most significant impact on the disease can be made by its prevention
    • thrombolytic and anticoagulant treatments are not indicated and only supportive care for such symptoms as hypertension, ulceration, and gangrene is advocated (1)
  • amputation of affected lower limb may be necessary; an end-diastolic pneumatic boot has been used as an alternative to amputation (2)

Prognosis depends on the extent of the systemic disease and a high rate of mortality (75-80%) is recorded due to multifactorial, cardiac, and renal aetiologies

Notes:

  • statins may help to stabilise atheromatous plaques
  • steroids have previously been used to attempt to reduce the inflammatory component

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.